Anteris Technologies Global Corp. Common Stock (AVR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) has a cash flow conversion efficiency ratio of -0.103x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-28.68 Million) by net assets ($278.41 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Anteris Technologies Global Corp. Common balance sheet independence to measure how much of total assets are equity-financed.
Anteris Technologies Global Corp. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Anteris Technologies Global Corp. Common (AVR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Anteris Technologies Global Corp. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anteris Technologies Global Corp. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cromwell Property Group
AU:CMW
|
0.023x |
|
Logwin AG
F:TGHN
|
0.138x |
|
Johns LYNG Group Ltd
AU:JLG
|
0.096x |
|
MASTERBRAND INC. DL-001
F:D55
|
0.065x |
|
Guangdong Dongpeng Holdings
SHE:003012
|
0.029x |
|
Close Brothers Group plc
F:CS3
|
-0.084x |
|
Guilin Seamild Foods Co Ltd
SHE:002956
|
0.078x |
|
Sichuan Jiuyuan Yinhai Software Co Ltd
SHE:002777
|
0.137x |
Annual Cash Flow Conversion Efficiency for Anteris Technologies Global Corp. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Anteris Technologies Global Corp. Common Stock from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Anteris Technologies Global Corp. Common market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-253.00K | $-77.80 Million | 307.522x | +31575.77% |
| 2024-12-31 | $62.68 Million | $-61.24 Million | -0.977x | +46.69% |
| 2023-12-31 | $18.90 Million | $-34.63 Million | -1.833x | +43.73% |
| 2022-12-31 | $9.03 Million | $-29.42 Million | -3.257x | -137.39% |
| 2021-12-31 | $10.52 Million | $-14.44 Million | -1.372x | +77.03% |
| 2020-12-31 | $1.86 Million | $-11.08 Million | -5.971x | -- |
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT ant… Read more